| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Payment of tempesta note | 50 | 50 |
| Payment of convertible notes | 50 | 20 |
| Total cash provided by financing activities | 13,880 | 7,621 |
| Effects of foreign exchange rate changes on assets and liabilities | -103 | 93 |
| Net increase (decrease) in cash | -4,475 | -5,795 |
| Cash and cash equivalents at beginning of period | 8,002 | - |
| Cash and cash equivalents at end of period | 3,527 | - |
Jaguar Health, Inc. (JAGX)
Jaguar Health, Inc. (JAGX)